EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Secondary malignancies among mantle cell lymphoma patients

Kossi D Abalo, Karin E Smedby, Sara Ekberg, Sandra Eloranta, Simon Pahnke, Alexandra Albertsson-Lindblad, Mats Jerkeman, Ingrid Glimelius

European Journal of Cancer · 2023

DOI: 10.1016/j.ejca.2023.113403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Kossi D Abalo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Sweden; Department of Medicine Solna, Clinical Epide…. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Mantle-CellMaleAdultHumansBendamustine HydrochlorideAntineoplastic Combined Chemotherapy ProtocolsRituximabCyclophosphamide

Stichwörter der Autor:innen

IbrutinibLenalidomideMantle cell lymphomaNordic-MCL2R-CHOPR-CHOP/CytarabineR-bendamustineSecondary malignancy

Substanzen

Bendamustine HydrochlorideRituximabCyclophosphamide

Autor:innen und Institutionen

  • Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Sweden; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden. Electronic…
  • Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
  • Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Sweden.
  • Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden.
  • Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Sweden; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.

Förderung

  • Cancerfonden

Zitieren

APA

Abalo, K. D., Smedby, K. E., Ekberg, S., Eloranta, S., Pahnke, S., Albertsson-Lindblad, A., Jerkeman, M., & Glimelius, I. (2023). Secondary malignancies among mantle cell lymphoma patients. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113403

Vancouver

Abalo KD, Smedby KE, Ekberg S, Eloranta S, Pahnke S, Albertsson-Lindblad A, et al. Secondary malignancies among mantle cell lymphoma patients. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113403

BibTeX
@article{Abalo2023,
  author = {Abalo, Kossi D and Smedby, Karin E and Ekberg, Sara and Eloranta, Sandra and Pahnke, Simon and Albertsson-Lindblad, Alexandra and Jerkeman, Mats and Glimelius, Ingrid},
  title = {Secondary malignancies among mantle cell lymphoma patients},
  journal = {European Journal of Cancer},
  year = {2023},
  doi = {10.1016/j.ejca.2023.113403}
}
Kostenlos starten →